About ProJect Pharmaceutics
ProJect Pharmaceutics is a company based in Planegg (Germany) founded in 2010 by Andreas Schutz and Klaus Hellerbrand. It operates as a B2B. ProJect Pharmaceutics offers products and services including Drug Formulation Development, Cytotoxic Drug Development, Lyophilization Process Development, High Protein Concentration Formulations, and Aseptic Preclinical Batch Manufacturing. ProJect Pharmaceutics operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
- Headquarter Planegg, Germany
- Founders Andreas Schutz, Klaus Hellerbrand
- SectorsHealthcare
- Website project-pharmaceutics.com
- Social LinkedIn X YouTube
- Legal Name Project Pharmaceutics Gmbh
Products & Services of ProJect Pharmaceutics
ProJect Pharmaceutics offers a comprehensive portfolio of products and services, including Drug Formulation Development, Cytotoxic Drug Development, Lyophilization Process Development, High Protein Concentration Formulations, and Aseptic Preclinical Batch Manufacturing.
Develops formulations for biopharmaceutics and drug delivery systems.
Formulates and processes cytotoxic drugs including ADCs.
Creates efficient freeze drying cycles for drug manufacturing.
Develops formulations for proteins in syringes and cartridges.
Produces non-GMP batches for preclinical studies.
Apps and channels of ProJect Pharmaceutics
its YouTube channel ProJect Pharmaceutics has 75 subscribers and 10 videos.
Videos from ProJect Pharmaceutics
The most watched videos on ProJect Pharmaceutics's YouTube channel, ProJect Pharmaceutics (75 subscribers). Click a video to play it here.
More on ProJect Pharmaceutics.
People of ProJect Pharmaceutics
2 people are tracked at ProJect Pharmaceutics (2 in leadership).
| Name | Role | Group |
|---|---|---|
Andreas Schutz | Co-Founder, MD | Leadership |
Klaus Hellerbrand | Co-Founder, MD | Leadership |
Complete people profiles for ProJect Pharmaceutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of ProJect Pharmaceutics
ProJect Pharmaceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abzena.com | 2001 | Cambridge, United Kingdom | $67.11M | 306 | Provider of antibody discovery, cell line development, and bio analytics services | |
| patheon.com | 1974 | Durham, United States | $141M | – | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | |
| syngeneintl.com | 1993 | Bengaluru, India | $85.89M | 5,618 | Provider of contract research and manufacturing services for both small molecules and biologics | |
| piramal.com | 1984 | Mumbai, India | – | 204 | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | |
| lakepharma.com | 2009 | Belmont, United States | $30M | 212 | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | |
| maravai.com | 2014 | San Diego, United States | – | 650 | Provides enabling tools and services in the life sciences research and bio-production industries | |
| grandriverasepticmfg.com | 2010 | Grand Rapids, United States | $16.93M | 293 | Sterile parenteral CDMO services for development and manufacturing are offered. | |
| panaceabiotec.com | 1984 | Ambala, India | – | 2,095 | Developer of biosimilars, vaccines and natural products | |
| obiosh.com | 2013 | Shanghai, China | $87.09M | – | OBiO Technology is engaged in cell and gene therapy solutions. |
Detailed competitors of ProJect Pharmaceutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProJect Pharmaceutics
Websites that share an audience with ProJect Pharmaceutics (project-pharmaceutics.com).
Websites whose visitors overlap most with ProJect Pharmaceutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mk2.bio | 100% | – | – | View details | |
| leukocare.com | 99% | 5.7K | #3,715,251 | View details | |
| eisbach.bio | 98% | 1.7K | #10,492,522 | View details | |
| tubulis.com | 96% | 19.5K | #1,280,536 | View details | |
| insempra.bio | 90% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for ProJect Pharmaceutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to ProJect Pharmaceutics
10 companies that operate in the same segment as ProJect Pharmaceutics (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProJect Pharmaceutics
ProJect Pharmaceutics was founded in 2010.
ProJect Pharmaceutics is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
ProJect Pharmaceutics focuses on formulation and process development for parenteral drug products, including proteins, peptides, and antibody drug conjugates. They use quality-by-design methods for biopharmaceutics and cytotoxics, offering services like lyophilization and analytical development. Based in Martinsried, Germany, they serve the pharmaceutical and biotech industry with expertise in sterile manufacturing and technology transfer.
ProJect Pharmaceutics's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
ProJect Pharmaceutics offers Drug Formulation Development, Cytotoxic Drug Development, Lyophilization Process Development, High Protein Concentration Formulations, and Aseptic Preclinical Batch Manufacturing.
ProJect Pharmaceutics operates through Project Pharmaceutics Gmbh.